![conference banner](/images/conference-banner.jpeg)
Abstract
Critical illness is associated with multiple system organ dysfunction, and neurologic dysfunction is increasingly assessed and recognized. Neurologic dysfunction includes encephalopathy, cognitive, neuromuscular and psychiatric impairments, all of which can be severe and are associated with significant morbidity. Medical technological advances have improved central nervous system monitoring in critically ill patients, allowing quick and reliable diagnosis neurologic dysfunction such as delirium, sensory processing deficits, seizures, and encephalopathy to name a few. A number of neurologic evaluation tools are available to assess the neurologic status of critically ill patients both acutely, as well as longterm. Each tool provides unique information regarding neurologic status and has associated strengths and weakness. Identification of neurologic dysfunction allows for the development of working plans for prognostication, therapeutics, and rehabilitation that address the needs of each ICU survivor. This review focuses on the evaluation of neurologic sequelae during critical illness and long-term neurologic outcomes in survivors of critical illness.
Keywords: Cognitive sequelae, neurologic dysfunction, depression, quality of life, critical illness, ICU
Current Respiratory Medicine Reviews
Title: Neurologic Sequelae in Critical Illness: Evaluation and Outcomes
Volume: 3 Issue: 4
Author(s): Mary R. Suchyta and Ramona O. Hopkins
Affiliation:
Keywords: Cognitive sequelae, neurologic dysfunction, depression, quality of life, critical illness, ICU
Abstract: Critical illness is associated with multiple system organ dysfunction, and neurologic dysfunction is increasingly assessed and recognized. Neurologic dysfunction includes encephalopathy, cognitive, neuromuscular and psychiatric impairments, all of which can be severe and are associated with significant morbidity. Medical technological advances have improved central nervous system monitoring in critically ill patients, allowing quick and reliable diagnosis neurologic dysfunction such as delirium, sensory processing deficits, seizures, and encephalopathy to name a few. A number of neurologic evaluation tools are available to assess the neurologic status of critically ill patients both acutely, as well as longterm. Each tool provides unique information regarding neurologic status and has associated strengths and weakness. Identification of neurologic dysfunction allows for the development of working plans for prognostication, therapeutics, and rehabilitation that address the needs of each ICU survivor. This review focuses on the evaluation of neurologic sequelae during critical illness and long-term neurologic outcomes in survivors of critical illness.
Export Options
About this article
Cite this article as:
Suchyta R. Mary and Hopkins O. Ramona, Neurologic Sequelae in Critical Illness: Evaluation and Outcomes, Current Respiratory Medicine Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339807782359904
DOI https://dx.doi.org/10.2174/157339807782359904 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacologic Treatment of Pulmonary Arterial Hypertension
Current Pharmaceutical Design Acute Human Toxicity of Macrocyclic Lactones
Current Pharmaceutical Biotechnology A Systematic Review and Meta-analysis of Efficacy and Safety of Calcimimetic Agents in the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
Current Pharmaceutical Design Editorial: [Hot Topic: Antidotes and Rescue Therapies]
Current Pharmaceutical Biotechnology Does the Association Between Anxiety and Parkinsons Disease Really Exist? A Literature Review
Current Psychiatry Reviews Polyphenols from Red Wine Modulate Immune Responsiveness: Biological and Clinical Significance
Current Pharmaceutical Design Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> and Virulence Genes in Pediatric Patients with Health-Care Urinary Tract Infections
Infectious Disorders - Drug Targets Oleic Acid in Olive Oil: From a Metabolic Framework Toward a Clinical Perspective
Current Pharmaceutical Design CB1 Cannabinoid Antagonists: Structure-Activity Relationships and Potential Therapeutic Applications
Current Topics in Medicinal Chemistry Antipsychotic Polypharmacy
Current Pharmaceutical Design Pulmonary Embolism Response Team (PERT) - A New Paradigm for the Treatment of Pulmonary Embolism
Current Pharmaceutical Design Involvement of Leukotriene Pathway in the Pathogenesis of Ischemia- Reperfusion Injury and Septic and Non-Septic Shock
Current Vascular Pharmacology Rationale of Hyperbaric Oxygenation in Cerebral Vascular Insult
Current Vascular Pharmacology Adrenomedullin in Heart Failure: Molecular Mechanism and Therapeutic Implication
Current Hypertension Reviews Endothelin-1 Actions on Vascular Smooth Muscle Cell Functions As a Target for the Prevention of Atherosclerosis
Current Vascular Pharmacology The Use of TNF Family Ligands and Receptors and Agents which Modify their Interaction as Therapeutic Agents
Current Drug Targets Attacking HIV Provirus: Therapeutic Strategies to Disrupt Persistent Infection
Infectious Disorders - Drug Targets Levosimendan: A Novel Agent in Heart Failure
Recent Patents on Cardiovascular Drug Discovery Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research
Current Pharmaceutical Design Treating Benign Prostatic Hyperplasia with Botulinum Neurotoxin
Current Medicinal Chemistry